Hassel Bjørnar, Elsais Ahmed, Frøland Anne-Sofie, Taubøll Erik, Gjerstad Leif, Quan Yi, Dingledine Raymond, Rise Frode
Department of Neurology, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Norwegian Defence Research Establishment, Kjeller, Norway.
J Neurochem. 2015 May;133(4):572-81. doi: 10.1111/jnc.13079. Epub 2015 Mar 13.
Fructose reacts spontaneously with proteins in the brain to form advanced glycation end products (AGE) that may elicit neuroinflammation and cause brain pathology, including Alzheimer's disease. We investigated whether fructose is eliminated by oxidative metabolism in neocortex. Injection of [(14) C]fructose or its AGE-prone metabolite [(14) C]glyceraldehyde into rat neocortex in vivo led to formation of (14) C-labeled alanine, glutamate, aspartate, GABA, and glutamine. In isolated neocortical nerve terminals, [(14) C]fructose-labeled glutamate, GABA, and aspartate, indicating uptake of fructose into nerve terminals and oxidative fructose metabolism in these structures. This was supported by high expression of hexokinase 1, which channels fructose into glycolysis, and whose activity was similar with fructose or glucose as substrates. By contrast, the fructose-specific ketohexokinase was weakly expressed. The fructose transporter Glut5 was expressed at only 4% of the level of neuronal glucose transporter Glut3, suggesting transport across plasma membranes of brain cells as the limiting factor in removal of extracellular fructose. The genes encoding aldose reductase and sorbitol dehydrogenase, enzymes of the polyol pathway that forms glucose from fructose, were expressed in rat neocortex. These results point to fructose being transported into neocortical cells, including nerve terminals, and that it is metabolized and thereby detoxified primarily through hexokinase activity. We asked how the brain handles fructose, which may react spontaneously with proteins to form 'advanced glycation end products' and trigger inflammation. Neocortical cells took up and metabolized extracellular fructose oxidatively in vivo, and isolated nerve terminals did so in vitro. The low expression of fructose transporter Glut5 limited uptake of extracellular fructose. Hexokinase was a main pathway for fructose metabolism, but ketohexokinase (which leads to glyceraldehyde formation) was expressed too. Neocortical cells also took up and metabolized glyceraldehyde oxidatively.
果糖会在大脑中与蛋白质自发反应,形成晚期糖基化终产物(AGE),这些产物可能引发神经炎症并导致脑部病变,包括阿尔茨海默病。我们研究了果糖是否通过新皮质中的氧化代谢被清除。在体内将[¹⁴C]果糖或其易生成AGE的代谢物[¹⁴C]甘油醛注射到大鼠新皮质中,导致形成了¹⁴C标记的丙氨酸、谷氨酸、天冬氨酸、GABA和谷氨酰胺。在分离的新皮质神经末梢中,[¹⁴C]果糖标记了谷氨酸、GABA和天冬氨酸,表明果糖被摄取到神经末梢中,并在这些结构中进行氧化果糖代谢。己糖激酶1的高表达支持了这一点,它将果糖导入糖酵解途径,并且以果糖或葡萄糖作为底物时其活性相似。相比之下,果糖特异性的酮己糖激酶表达较弱。果糖转运体Glut5的表达水平仅为神经元葡萄糖转运体Glut3的4%,这表明跨脑细胞质膜的转运是清除细胞外果糖的限制因素。编码醛糖还原酶和山梨醇脱氢酶(这两种酶是从果糖形成葡萄糖的多元醇途径中的酶)的基因在大鼠新皮质中表达。这些结果表明果糖被转运到包括神经末梢在内的新皮质细胞中,并且它主要通过己糖激酶活性进行代谢从而解毒。我们研究了大脑如何处理果糖,果糖可能会与蛋白质自发反应形成“晚期糖基化终产物”并引发炎症。新皮质细胞在体内摄取并氧化代谢细胞外果糖,分离的神经末梢在体外也是如此。果糖转运体Glut5的低表达限制了细胞外果糖的摄取。己糖激酶是果糖代谢的主要途径,但酮己糖激酶(导致甘油醛形成)也有表达。新皮质细胞也摄取并氧化代谢甘油醛。